{"id":211846,"name":"MEDICATION ASSISTED TREATMENT LEADERSHIP COUNCIL","slug":"medication-assisted-treatment-leadership-council","state":"TX","country":"United States of America","description":"Opioid treatment program facilities and practices","totalSpending":870000,"filings":19,"yearlySpending":[{"year":2021,"income":70000},{"year":2022,"income":200000},{"year":2023,"income":200000},{"year":2024,"income":200000},{"year":2025,"income":200000}],"issues":["HCR","MMM"],"firms":["FEDERAL HEALTH POLICY STRATEGIES"],"lobbyists":["DAN ELLING","COOKAB HASHEMI"],"govEntities":["Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Opioid use disorder treatment coverage, funding and reimbursement","Opioid use disorder treatment coverage, funding and reimbursement","Policies impacting the provision and regulation of medication assisted treatment\nProposed CY21 Medicare Physician Fee Schedule \nHR 1384 Mainstreaming Addiction Treatment Counseling Act","Policies impacting the provision and regulation of medication assisted treatment\nCoverage of opioid use disorder treatment","Policies impacting the provision and regulation of medication assisted treatment Coverage of opioid use disorder treatment H.R.6279--Opioid Treatment Access Act H.R. 1364--Mainstreaming Addiction Trea"],"years":[2021,2022,2023,2024,2025]}